Brief: Elos Medtech Q4 Operating Profit Up At SEK 14.1 Mln

Elos Medtech AB

18/02/2020 13:24

Feb 18 (Reuters) - Elos Medtech AB  ELOSSb.ST :
    * YEAR-END REPORT, 1 JANUARY - 31 DECEMBER, 2019
    * BOARD OF DIRECTORS PROPOSES A DIVIDEND OF SEK 1.50 PER
SHARE FOR
FINANCIAL YEAR 2019
    * OUR SITE IN CHINA HAS BEEN CLOSED DUE TO VIRUS OUTBREAK,
AND AT
TIME OF WRITING OPERATIONS WILL BE PARTLY RESUMED
    * SALES AND EARNINGS WILL BE SLIGHTLY LOWER AT BEGINNING OF
2020
    * MARKET DEMAND FOR OUR CONTRACT MANUFACTURING SERVICES IN
LIFE
SCIENCE IS STRONG AND OUR POLYMER BUSINESS IN BUSINESS AREA
CONTINUES TO GROW
    * OUR SITE IN CHINA HAS BEEN CLOSED DUE TO VIRUS OUTBREAK,
AND AT
TIME OF WRITING OPERATIONS WILL BE PARTLY RESUMED
    * Q4 NET SALES SEK 158.3  MILLION VERSUS SEK 168.9 MILLION
YEAR
AGO
    * Q4 OPERATING PROFIT SEK 14.1  MILLION VERSUS SEK 11.0
MILLION
YEAR AGO
    * CHINA SITE CLOSURE WILL EFFECT SALES AND EARNINGS THAT
WILL BE
SLIGHTLY LOWER AT BEGINNING OF 2020

Source text for Eikon:  ID:nWkrS7Xrc 
Further company coverage:  ELOSSb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))